Efficacy and safety of rosuvastatin in treatment of dyslipidemia.
about
Comparison of the Risk of Gastrointestinal Bleeding among Different Statin Exposures with Concomitant Administration of Warfarin: Electronic Health Record-Based Retrospective Cohort StudyMore potent lipid-lowering effect by rosuvastatin compared with fluvastatin in everolimus-treated renal transplant recipients.How can we manage hyperlipidemia and avoid rhabdomyolysis in transplant patients?A review on the rationale and clinical use of concomitant rosuvastatin and fenofibrate/fenofibric acid therapy.Comparison of Efficacy and Safety of Rosuvastatin, Atorvastatin and Pravastatin among Dyslipidemic Diabetic PatientsEfficacy and safety of rosuvastatin in the management of dyslipidemiaOpen-label, ascending dose, prospective cohort study evaluating the antiviral efficacy of Rosuvastatin therapy in serum and lipid fractions in patients with chronic hepatitis CComparison of efficacy, safety, and cost-effectiveness of various statins in dyslipidemic diabetic patients.Potential statin-drug interactions: prevalence and clinical significanceSurface modification of endovascular stents with rosuvastatin and heparin-loaded biodegradable nanofibers by electrospinning.Intraperitoneal administration of rosuvastatin prevents postoperative peritoneal adhesions by decreasing the release of tumor necrosis factor.Influence of APOA5 Locus on the Treatment Efficacy of Three Statins: Evidence From a Randomized Pilot Study in Chinese Subjects.
P2860
Q28552407-0C2108D3-9799-469E-9B09-E9B39AE5B20EQ34023028-7EAD193C-E3A8-41F1-B6BF-3A2B6B4B80A0Q34808267-CB1A9F5D-471F-43B8-B67F-6CE2BFDA9FBAQ35683911-EDF05FA5-6D7F-4759-B06D-A5601719E275Q36637890-A44A70A2-7C99-49F2-9E38-94A5643F8365Q37167517-1054A96E-6B6E-465D-A05E-3A972E9C50BDQ37304715-BEACFA91-A041-4A1A-BAC1-C418C1748EE1Q37551536-5385298C-59DB-40D2-B7B9-16A9CBE5E0DBQ37724896-DB5AD23B-E1EA-4E00-8C66-D5BEC117F3C7Q41634009-B7B53134-AC5F-4B91-978E-49CD15567A35Q49697110-B7295715-82CF-443E-9D81-7125AD5C4B32Q55017020-39826952-E318-4FB3-B7C3-1FBF166778A4
P2860
Efficacy and safety of rosuvastatin in treatment of dyslipidemia.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Efficacy and safety of rosuvastatin in treatment of dyslipidemia.
@ast
Efficacy and safety of rosuvastatin in treatment of dyslipidemia.
@en
Efficacy and safety of rosuvastatin in treatment of dyslipidemia.
@nl
type
label
Efficacy and safety of rosuvastatin in treatment of dyslipidemia.
@ast
Efficacy and safety of rosuvastatin in treatment of dyslipidemia.
@en
Efficacy and safety of rosuvastatin in treatment of dyslipidemia.
@nl
prefLabel
Efficacy and safety of rosuvastatin in treatment of dyslipidemia.
@ast
Efficacy and safety of rosuvastatin in treatment of dyslipidemia.
@en
Efficacy and safety of rosuvastatin in treatment of dyslipidemia.
@nl
P356
P1476
Efficacy and safety of rosuvastatin in treatment of dyslipidemia
@en
P2093
James M McKenney
P304
P356
10.1093/AJHP/62.10.1033
P577
2005-05-01T00:00:00Z